Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Says WHO Drops Redefinition Of Generics As Counterfeit

This article was originally published in PharmAsia News

Executive Summary

Indian pharmaceuticals were cheered by a decision of the World Health Organization not to take the route of the European Union and consider generic drugs as counterfeit. The WHO had considered such a move, but India and Brazil launched major campaigns against it and the UN organization decided it would not do so in a determination that has not been made official. The WHO killed a resolution that would have adopted the definition at a recent meeting. India and Brazil, members of the group, argued the WHO's role was in public health, not intellectual property rights. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts